404: Page not Found
To find an doctor profile, first select a location from the home page and then search.
If you can't find the page you're looking for using the navigation above, please Contact Us.
To find an doctor profile, first select a location from the home page and then search.
If you can't find the page you're looking for using the navigation above, please Contact Us.
In making selections for Super Doctors, MSP Communications employs a rigorous multi-step process designed to identify healthcare providers who have attained a high degree of peer recognition and professional achievement. Super Doctors is a selective yet diverse listing of outstanding doctors, representing consumer-oriented medical specialties.
"Off-label" Use of Antipsychotic Drugs for Some Conditions Not Supported by Evidence
There is little evidence to support the use of atypical antipsychotic drugs for some treatments other than their officially approved purposes, even though many clinicians continue to commonly prescribe these drugs for so-called "off label"
One year after launching its expanded Overdose Expansion Strategy, the U.S. Department of Health and Human Services (HHS) reveals the progress made by increasing the capacity to treat addiction
Mayo Receives Federal Grant to Develop Smart Devices to Predict, Stop Seizures
The grant, part of a presidential initiative aimed at revolutionizing the understanding of the human brain, is called Brain Research Through Advancing Innovative Neurotechnologies or the BRAIN Initiative.
NIH-funded analysis finds patients treated with semaglutide had 49% to 73% lower risk of suicidal ideation than those given other medications.
Super Doctors identifies top doctors as selected by their peers and the independent research of MSP Communications. Please note: Doctors cannot pay to be included on Super Doctors® listings nor are they paid to provide input.
Super Doctors is published online and also in print as a special advertising section in leading newspapers and city and regional magazines.